Abstract:
Aim of the study: Clarification of the time of clinical improvement after management of COVID-19 pneumonia versus the normal progression of the common workup is the target for the current study.
Background: COVID-19 pneumonia is a current serious international pandemic infection. Generally, in medical diseases, the clinical response is commonly parallel to laboratory and radiological improvement. This rule may be different in COVID-19 pneumonia.
Method of study and patients: The author reported a retrospective-observational 47-case report series. The study was conducted in a physician outpatient clinic thorough nearly 12-months, starting from Jun 9, 2020, and, ended on May 8, 2021. All included cases were COVID-19 pneumonia and treated with conventional antibiotics, anticoagulants, and steroids.
Results: The mean ±SD age was 50.08 (14.9) years, with male sex predominance (55.32%). The mean days of clinical versus leukocytosis, neutrophilia, and lymphopenia improvement were 0.84 ±0.49, 13.05 ±6.44, 13.05 ±7.01, and 13.05 ±7.01.The mean ±SD days of clinical versus CRP, D-dimer, s. ferritin, and LDH improvement (0.84 ±0.49, 12.2 ±3.25, 12.2 ±6.21, 12.3 ±5.46, 20.92± 9.48). The mean days of clinical versus radiological and electrocardiographic improvement were 0.84 ± 0.49, 15.74 ± 5.25, and 11.45 ± 5.45, respectively. The test was statistically significant in all the above tests (p-value is < .00001).
Conclusions: Yasser’s COVID-19 Discrepancy phenomenon is a novel descriptive phenomenon that is always seen in all COVID-19 pneumonia. Initial dramatic improvement of the clinical status of COVID-19 pneumonic patient, not a simultaneously after the management, not coincide with laboratory, radiological, and electrocardiographic workup. Further larger studies for the study medical regimen with considering of “Yasser’s COVID-19 Discrepancy phenomenon” will be recommended.
Biography:
Dr. Yasser Mohammed Hassanain Elsayed is a scientist, critical care physician, cardiologist, and independent researcher at the Ministry of Health in Egypt. He has (160) publicized articles with (36) Innovations. They included (7) "Yasser’s sign", (8) "Yasser’s phenomenon", (1) "Yasser’s modification", (2) "Yasser’s maneuver", (1) “Yasser’s method”, (1) “Yasser’s test”, (8) “Yasser’s syndrome”, (1) "Yasser’s fibrillation", (1) "Yasser’s procedure", (1) Yasser’s ECG palpitations wave, (1) Factitious Yasser's infarction, (1) "Yasser’s criterion"", (1) "Yasser's conversions", (1) "Amiodarone off-phenomenon, and (1) "Yasser’s classification". He was an international speaker in (46) Conferences, (8) Keynote speaker, reviewed (more than 352 articles), was an honorable editor for (275) Journals, (16) Conferences, OCM, and was an instructor in (15) official and (150) non-official training. He has (54) COVID-19 publicized articles; He was nominated for big prizes such as the Breakthrough Prize, the Einstein Prize, the Shoman Award, the Mostafa Prize, etc. He gained (more than 191) excellence certificates.
